2509001333
  • Open Access
  • Mini Review

Thrombocytopenia in Epstein-Barr Virus Infection as A Hidden Clinical Clue

  • Yuxin Shao 1, 2, †,   
  • Liwei Gao 3, †,   
  • Jian Ge 4,   
  • Ran Wang 1, 2, 5, 6, *

Received: 10 Aug 2025 | Revised: 17 Sep 2025 | Accepted: 17 Sep 2025 | Published: 14 Oct 2025

Abstract

Thrombocytopenia is a frequently overlooked yet clinically relevant manifestation of Epstein-Barr virus (EBV) infection, particularly in children. Although it is commonly associated with EBV-related conditions, thrombocytopenia is often misdiagnosed as primary immune thrombocytopenia or dismissed as an incidental finding. This review summarizes current evidence linking EBV infection and thrombocytopenia, highlighting its potential as an early clinical clue. We emphasize the importance of timely EBV testing in pediatric patients with unexplained thrombocytopenia and advocate for greater clinical awareness and multidisciplinary research. Recognizing thrombocytopenia as more than a minor laboratory abnormality may improve diagnostic accuracy, guide appropriate treatment, and inform future research directions.

References 

  • 1.
    Schifferli, A.; Heiri, A.; Imbach, P.; et al. Misdiagnosed thrombocytopenia in children and adolescents: Analysis of the Pediatric and Adult Registry on Chronic ITP. Blood Adv. 2021, 5, 1617–1626.
  • 2.
    Yusuf, H.; Kou, A.; Zelinskas, C.; et al. Secondary Immune Thrombocytopenic Purpura Due to Primary Epstein-Barr Virus Infection. Cureus 2022, 14, e26112.
  • 3.
    Kim, J.K.; Jeon, J.S.; Kim, J.W.; et al. Correlation Between Abnormal Platelet Count and Respiratory Viral Infection in Patients from Cheonan, Korea. J. Clin. Lab. Anal. 2016, 30, 185–189.
  • 4.
    Nagori, E.K.; Ghantarchyan, H.; Qadir, A.; et al. COVID-19-Induced Thrombocytopenia: A Brief Literature Review and Case Report. Cureus 2022, 14, e30993.
  • 5.
    Kimura, H.; Ito, Y.; Kawabe, S.; et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: Prospective analysis of 108 cases. Blood 2012, 119, 673–686.
  • 6.
    Carter, R.L. Platelet Levels in Infectious Mononucleosis. Blood 1965, 25, 817–821.
  • 7.
    Likic, R.; Kuzmanic, D. Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection. Wien. Klin. Wochenschr. 2004, 116, 47–50.
  • 8.
    Pader, E.; Grossman, H. Thrombocytopenic purpura in infectious mononucleosis. N. Y. State J. Med. 1956, 56, 1905–1910.
  • 9.
    Pishmisheva-Peleva, M.; Kotsev, S.; Emin, D.; et al. Severe thrombocytopenia in primary EBV- Infection with no signs of infectious mononucleosis. A case report. IDCases 2022, 30, e01643.
  • 10.
    Wu, Z.; Zhou, J.; Wei, X.; et al. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia. Hematology 2013, 18, 295–299.
  • 11.
    Audia, S.; Mahevas, M.; Samson, M.; et al. Pathogenesis of immune thrombocytopenia. Autoimmun. Rev. 2017, 16, 620–632.
  • 12.
    Raadsen, M.; Du Toit, J.; Langerak, T.; et al. Thrombocytopenia in Virus Infections. J. Clin. Med. 2021, 10, 877.
  • 13.
    Arai, A. Chronic active Epstein-Barr virus infection: A bi-faceted disease with inflammatory and neoplastic elements. Immunol. Med. 2018, 41, 162–169.
  • 14.
    Rasizadeh, R.; Ebrahimi, F.; Zamani Kermanshahi, A.; et al. Viruses and thrombocytopenia. Heliyon 2024, 10, e27844.
Share this article:
How to Cite
Shao, Y.; Gao, L.; Ge, J.; Wang, R. Thrombocytopenia in Epstein-Barr Virus Infection as A Hidden Clinical Clue. Disease Biology, Genetics, and Socioecology 2025, 1 (4), 10. https://doi.org/10.53941/dbgs.2025.100010.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2025 by the authors.